Buy Strides Arcolab advises Tulsian

SP Tulsian of sptulsian.com recommended buying Strides Arcolab. The stock rallied 5.5 percent on Friday.

Tulsian told CNBC-TV18, “Second stock I am recommending is Stride Arcolab. The sell of its Agila Specialities division to Pfizer for a valuation of over USD 2 billion is again coming into the rounds. On Friday, we have seen the good buying take place in the stock.” Shares rallied 5.5 percent to close at Rs 1,036.55 amid large volumes on Bombay Stock Exchange on Friday. Trading volumes increased 108 percent to 3,19,787 equity shares as against five day average of 1,53,498 shares.